Localization and Excision of Occult Breast Lesions
Overview
Affiliations
Between 1976 and 1982, 190 non-palpable mammographic abnormalities considered to be suspicious of malignancy were excised using a needle localization technique. The indications for biopsy, technique for localization, method for confirmation of excision and histopathological preparation are presented. The histopathological diagnosis of these lesions were 150 benign and 40 malignant. There was no clear correlation between the mammographic appearances and the occurrence of cancer. Compared with 100 consecutive women with palpable breast cancer the impalpable and mammographically detected tumours were smaller, more often non-invasive and associated with negative axillary nodes.
Breast biopsy rate and positivity in Rhode Island.
Richards M, Feldman J, Smith R, Debuono B Am J Public Health. 1994; 84(8):1310-2.
PMID: 8059892 PMC: 1615481. DOI: 10.2105/ajph.84.8.1310.
The Edinburgh randomised trial of screening for breast cancer: description of method.
Roberts M, Alexander F, Anderson T, Forrest A, Hepburn W, Huggins A Br J Cancer. 1984; 50(1):1-6.
PMID: 6743506 PMC: 1976924. DOI: 10.1038/bjc.1984.132.
Mammographic identification and biopsy of occult breast cancer.
Lee M, Lee J, Thompson H, Oates G Ann R Coll Surg Engl. 1986; 68(4):188-90.
PMID: 3789603 PMC: 2498406.
Role of fine needle aspiration cytology in breast cancer screening.
Lamb J, Anderson T, Dixon M, Levack P J Clin Pathol. 1987; 40(7):705-9.
PMID: 3624497 PMC: 1141084. DOI: 10.1136/jcp.40.7.705.
Oestrogen receptor activity in breast cancer detected at a prevalence screening examination.
Roberts M, Hawkins R, Alexander F, Anderson T, Steele R Breast Cancer Res Treat. 1987; 10(3):267-72.
PMID: 3447645 DOI: 10.1007/BF01805763.